0001179110-21-001553.txt : 20210210
0001179110-21-001553.hdr.sgml : 20210210
20210210190726
ACCESSION NUMBER: 0001179110-21-001553
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210208
FILED AS OF DATE: 20210210
DATE AS OF CHANGE: 20210210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patel Sanj K
CENTRAL INDEX KEY: 0001532218
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38492
FILM NUMBER: 21615789
MAIL ADDRESS:
STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD.
STREET 2: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd.
CENTRAL INDEX KEY: 0001730430
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
BUSINESS PHONE: 7814399100
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
edgar.xml
FORM 4 -
X0306
4
2021-02-08
0
0001730430
Kiniksa Pharmaceuticals, Ltd.
KNSA
0001532218
Patel Sanj K
C/O KINIKSA PHARMACEUTICALS, LTD.
CLARENDON HOUSE 2 CHURCH STREET
HAMILTON
D0
HM11
BERMUDA
1
1
0
0
Chairman & CEO
Class A Common Shares
2021-02-08
4
M
0
4924
1.59
A
4924
D
Class A Common Shares
2021-02-08
4
S
0
4924
23.00
D
0
D
Class A Common Shares
2021-02-09
4
M
0
20401
1.59
A
20401
D
Class A Common Shares
2021-02-09
4
S
0
20401
23.04
D
0
D
Class A Common Shares
2021-02-08
4
S
0
4528
23.00
D
108042
I
Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013
Class A Common Shares
2021-02-09
4
S
0
23569
23.08
D
84473
I
Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013
Class A Common Shares
2021-02-10
4
M
0
1600
1.59
A
1600
D
Class A Common Shares
2021-02-10
4
S
0
1600
23.06
D
0
D
Class A Common Shares
2021-02-10
4
S
0
1137
23.07
D
83336
I
Held by the Anglia 2013 Revocable Trust, u/d/t August 15, 2013
Class A Common Shares
109795
I
Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016
Share Option
1.59
2021-02-08
4
M
0
4924
0
D
2025-12-15
Class A Common Shares
4924
347272
D
Share Option
1.59
2021-02-09
4
M
0
20401
0
D
2025-12-15
Class A Common Shares
20401
326871
D
Share Option
1.59
2021-02-10
4
M
0
1600
0
D
2025-12-15
Class A Common Shares
1600
325271
D
The transactions reported in this From 4 were effected pursuant to a Rule 10b5-1 plan executed by the reporting person on September 3, 2020.
The option is fully vested and exercisable.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.01. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.24. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.02. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.27. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.18. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $23.00 to $23.15. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
/s/ Thomas W. Beetham, Attorney-in-Fact For Sanj K Patel
2021-02-10